Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043586 · ClinicalTrials.gov registry record
Treatment Patterns and Treatment Outcomes for Acromegaly
A clinical trial of Acromegaly, sponsored by Columbia University.
- Completed
- Registry status
- 520
- Enrollment target
- 1
- Study location
NCT03043586 is a study of Acromegaly that has completed, run by Columbia University. The registered enrollment target is 520 participants, above the 61-participant average among 13 other Acromegaly trials with a reported enrollment target (752% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03043586, a study of Acromegaly, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a human, prospective and retrospective, single-center study of patients who have undergone treatment for acromegaly in New York City since 1981. The project will characterize, among other factors, the treatment methods received by patients, who administered the treatments and the success of this therapy in terms of biochemical control.
Conditions Studied
Study Locations (1)
New York
- Neuroendocrine Unit at Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2016-12 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03043586
The ClinicalTrials.gov registry entry for NCT03043586 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 520 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 13 other Acromegaly trials with a reported enrollment target (752% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acromegaly appearing as the primary indexed condition, and to 0 interventions.
NCT03043586 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03043586 about?
NCT03043586 is a clinical study titled "Treatment Patterns and Treatment Outcomes for Acromegaly". This is a human, prospective and retrospective, single-center study of patients who have undergone treatment for acromegaly in New York City since 1981. The project will characterize, among other factors, the treatment methods received by patients, who administered the treatments and the success of ...
What is the current status of trial NCT03043586?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2016-12. Estimated completion is 2025-04-30.
What conditions does trial NCT03043586 study?
This clinical trial studies the following conditions: Acromegaly.
Who is sponsoring clinical trial NCT03043586?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03043586 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acromegaly
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
RECRUITING · Phase 3
-
Diet in the Management of Acromegaly
RECRUITING · NA
-
Study of MAR002 in Healthy Men
RECRUITING · Phase 1
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
ACTIVE NOT RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.